Skip to Content
Contact Form Map & Directions Videos

Category: Blog

Congressional Hearing on Proposed FDA Rule Change

04/2/2014
Articles
BY

Yesterday afternoon, Congress’s Subcommittee on Health held a hearing to examine the FDA’s proposal to change the rules of generic drug labeling. Under the current law, enacted in 1984, warning labels for particular drug formulations are created by the brand-name manufacturers, and generic manufacturers are legally prevented from altering them. […]

Read More

CDC: Autism Rates Jump 30 Percent, Boys Most Affected

03/31/2014
Announcement
BY

When the mercury-based preservative thimerosol was slowly removed from childhood vaccines it was assumed that the astonishing rates of autism would decline. Autism is a brain abnormalty that makes children socially awkward if not totally withdrawn. For years it was suspected that mercury toxicity was behind cases of autism, estimated […]

Read More

The Penalty Game

03/31/2014
Articles
BY

Johnson and Johnson (J&J) and its subsidiary Janssen Pharmaceuticals have been dealing with multiple lawsuits stemming from its drug Risperdal. Shortly after dodging a $1.2 billion judgment in Arkansas, J&J has returned its focus to the multidistrict litigation (MDL) currently pending in Pennsylvania. The company is now trying to shield […]

Read More

When Money Influences Medicine

03/27/2014
Articles
BY

The Wall Street Journal reports on conflict of interest disclosures that have evolved as a result of transvaginal mesh (TVM) lawsuits filed against healthcare giant, Ethicon, a division of Johnson & Johnson. Amid the hundreds of thousands of pages of documents provided in the 17,000 cases filed in federal court […]

Read More

J&J Gets $1.2 Billion Pass on Risperdal Fine

03/27/2014
Defective Drugs
BY

Two years ago, healthcare giant Johnson & Johnson was facing a $1.2 billion judgment after a jury determined J&J concealed the risks of its antipsychotic drug Risperdal while it aggressively and improperly marketed it off-label. At the time it was the largest state fine over the mismarketing of Risperdal and […]

Read More

Brenda Fulmer Featured in Trial Magazine

03/25/2014
Announcement
BY

Congratulations, Brenda! We’ve reprinted the article below. Reprinted with permission of Trial (March 2014) Copyright American Association for Justice, formerly Association of Trial Lawyers of America (ATLA®) Gender equity in the law March 2014, Volume 50, No. 3 Sidebar: Brenda Fulmer: Working hard and staying true  Courtney L. Davenport When […]

Read More

Living Off the Label

03/24/2014
Articles
BY

Doctors and physicians are given a great deal of discretion when it comes to prescribing drugs for uses other than those indicated by the FDA. This is known as “off-label” use. The FDA, realizing the danger of off-label promotion in its 2009 guidance, has set forth rules to restrict the […]

Read More

Hear What Our Clients Have To Say

"The attorneys and staff at Searcy Denney are some of the most compassionate and caring individuals I have met in the legal field. They work tirelessly on behalf of their clients to ensure the best possible outcome. I would highly recommend them for anyone who is seeking excellent legal representation."
Posted By: Lauren Schumacher